Anxiolytic effects of a novel group II metabotropic glutamate receptor agonist (LY354740) in the fear-potentiated startle paradigm in humans
Open accessThe DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Abstract
RationaleLY354740, a structural analogue of glutamate that shows specificity at the mGluR2/3 receptor, has anxiolytic effects in animal models.ObjectiveThis study investigated the anxiolytic effects of LY354740 in humans using the fear-potentiated startle reflex methodology.MethodsSubjects were given either placebo (n=16), 20 mg LY354740 (n=15), or 200 mg LY354740 (n=13). The fear-potentiated startle tests examined startle potentiation to shock anticipation and to darkness.ResultsConsistent with previous results, startle was increased by threat of shock and by darkness. LY354740 did not affect baseline startle. Correspondingly, subjects did not report LY354740 to be sedative. LY354740 significantly reduced the increase in startle magnitude during shock anticipation, but not during darkness. Subjective reports of state anxiety and negative affectivity during the fear-potentiated startle tests were also reduced in a dose-dependent manner by LY354740.ConclusionsThese results suggest that LY354740 has an anxiolytic profile in humans without being sedative.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The role of the amygdala in fear and anxiety
Davis, M. (1992) · Annual Review of Neuroscience · doi:10.1146/annurev.ne.15.030192.002033 · Cited by 2,357
Emotion, attention, and the startle reflex
Lang, P. J., Bradley, M. M., & Cuthbert, B. N. (1990) · Psychological Review · doi:10.1037/0033-295x.97.3.377 · Cited by 2,205 · cited 1×
“The startle reflex is highly sensitive to aversive states in rodents and in humans (Lang et al. 1990; Davis 1992), an effect attributed to structures believed to be involved in fear and anxiety (e.g. the amygdala and bed nucleus of the stria terminalis) (Davis 1998).”
BackgroundWalker, D. L., & Davis, M. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-23-09375.1997 · Cited by 627 · cited 10×
“Lesions of the central nucleus of the amygdala block explicit cued fear-potentiated startle, but do not affect the facilitation of startle by bright lights (Walker and Davis 1997a).”
BackgroundResultInfluentialCharney, D. S. (1984) · Archives of General Psychiatry · doi:10.1001/archpsyc.1984.01790190025003 · Cited by 599 · cited 2×
“Subjective reports Analysis of the VAS ratings for the different adjectives assessing sedative effects was conducted with a two-way ANOVA with Treatment (Placebo, mGlu20, mGlu200) and Time (before, after ingestion) as the two factors.”
MethodBenzodiazepines: use, abuse, and consequences.
Woods, J. H., Katz, J. L., & Winger, G. (1992) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)00468-5 · Cited by 560 · cited 1×
“Interest in new anxiolytics stems from the fact that current anxiolytics, in particular the benzodiazepines, have undesirable side effects such as sedation and dependency (Dantzer 1977; Woods et al. 1992).”
BackgroundHitchcock, J., & Davis, M. (1986) · Behavioral Neuroscience · doi:10.1037/0735-7044.100.1.11 · Cited by 541
Fear‐Potentiated Startle in Humans: Effects of Anticipatory Anxiety on the Acoustic Blink Reflex
Grillon, C., AMELI, R., Woods, S. W., Merikangas, K., & Davis, M. (1991) · Psychophysiology · doi:10.1111/j.1469-8986.1991.tb01999.x · Cited by 462 · cited 5×
“Startle potentiation to an explicit threat signal can be obtained using either aversive conditioning or verbal threat procedures (Grillon et al. 1991; Grillon and Davis 1997).”
BackgroundMethodResultInfluentialSelf-citationBaseline and fear-potentiated startle in panic disorder patients
Grillon, C., Ameli, R., Goddard, A., Woods, S. W., & Davis, M. (1994) · Biological Psychiatry · doi:10.1016/0006-3223(94)90040-x · Cited by 212 · cited 4×
“Startle can also be facilitated by darkness in humans, increasing by about 15–20% when elicited in a dark room, compared to an illuminated room (Grillon et al. 1997a).”
BackgroundResultInfluentialSelf-citationAnxiogenic effects of high illumination levels assessed with the acoustic startle response in rats
Walker, D. L., & Davis, M. (1997) · Biological Psychiatry · doi:10.1016/s0006-3223(96)00441-6 · Cited by 211 · cited 8×
“Drugs that reduce anxiety in humans also reduce this “light-enhanced startle” (de Jongh et al. 2002; Walker and Davis 1997b, 2002a ).”
BackgroundResultInfluentialDarkness facilitates the acoustic startle reflex in humans
Grillon, C., Pellowski, M., Merikangas, K. R., & Davis, M. (1997) · Biological Psychiatry · doi:10.1016/s0006-3223(96)00466-0 · Cited by 193
Self-citationWalker, D., & Davis, M. (2002) · Psychopharmacology · doi:10.1007/s00213-002-1213-0 · Cited by 122 · cited 6×
“Drugs that reduce anxiety in humans also reduce this “light-enhanced startle” (de Jongh et al. 2002; Walker and Davis 1997b, 2002a).”
BackgroundInfluentialBenzodiazepines have no effect on fear-potentiated startle in humans
Baas, J., Grillon, C., Böcker, K., Brack, A., Morgan, C., Kenemans, L., & Verbaten, M. (2002) · Psychopharmacology · doi:10.1007/s00213-002-1011-8 · Cited by 116
Self-citationLight-enhanced startle: further pharmacological and behavioral characterization
Walker, D. L., & Davis, M. (2002) · Psychopharmacology · doi:10.1007/s002130100913 · Cited by 101
de Jongh, R., Groenink, L., van der Gugten, J., & Olivier, B. (2002) · Psychopharmacology · doi:10.1007/s002130100914 · Cited by 70
Bitsios, P., Philpott, A., Langley, R. W., Bradshaw, C. M., & Szabadi, E. (1999) · Journal of Psychopharmacology · doi:10.1177/026988119901300303 · Cited by 69
Riba, J., Rodríguez-Fornells, A., Urbano, G., Morte, A., Antonijoan, R., & Barbanoj, M. (2001) · Psychopharmacology · doi:10.1007/s002130100816 · Cited by 60
Walker, D. L., Rattiner, L. M., & Davis, M. (2002) · Behavioral Neuroscience · doi:10.1037/0735-7044.116.6.1075 · Cited by 53
C., G., & J., B. (2002) · Psychopharmacology · doi:10.1007/s00213-002-1164-5 · Cited by 27 · cited 3×
“The reduction of fear-potentiated startle by LY354047 cannot be explained by a non-specific sedative effect of the drug on baseline startle, which would prevent accurate assessment of fear-potentiated startle (Grillon and Baas 2002; Walker and Davis 2002b).”
Background
Cited by
Allosteric modulators of GPCRs: a novel approach for the treatment of CNS disorders
Jeffrey Conn, P., Christopoulos, A., & Lindsley, C. W. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2760 · Cited by 1,063
Clinical biomarkers in drug discovery and development
Frank, R., & Hargreaves, R. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1130 · Cited by 794
Ionotropic and metabotropic glutamate receptor structure and pharmacology
Kew, J. N. C., & Kemp, J. A. (2005) · Psychopharmacology · doi:10.1007/s00213-005-2200-z · Cited by 788
Cryan, J. F., & Mombereau, C. (2004) · Molecular Psychiatry · doi:10.1038/sj.mp.4001457 · Cited by 616
“This dissociation of the two disorders is also reflected in currently available early proof-of-concept clinical trials in humans, where panic (via CCK agonist, CO 2 or lactate) or fear (via fear potentiated startle) provocation tests are available and carried out in healthy volunteers in addition to patients”
ResultMetabotropic glutamate receptors as novel targets for anxiety and stress disorders
Swanson, C. J., Bures, M., Johnson, M. P., Linden, A.-M., Monn, J. A., & Schoepp, D. D. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1630 · Cited by 607
Metadata
- Authors
- Grillon, C., Cordova, J., Levine, L. R., & Morgan, III
- Venue
- Psychopharmacology
- Published
- 2003-08-01
- Volume
- 168
- Issue
- 4
- Pages
- 446-454
- ISSN
- 0033-3158 (ISSN-L)
- 1432-2072
- OpenAlex
- W2008956763
- Cited by
- 185
- References
- 18
- FWCI
- 7.89
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.